Sale is live|00:00:00

S H Kelkar & Company Ltd Q4 FY26 Earnings Analysis

Published 14 Jun 2026 | Chemicals & Petrochemicals | Market Cap: ₹1.9K Cr

Price

128

Market Cap

₹1.9K Cr

P/E Ratio

38.1

Earnings Summary

- The company targets a 12% year-on-year CAGR growth with FY '24-'25 as the base year. - Flavours EBIT margins expected to remain steady at 20%-22% through FY27-FY28.

📊 Revenue & Sales Performance

- The company targets a 12% year-on-year CAGR growth with FY '24-'25 as the base year. - Additional capacity in Southeast Asia (3,600 tons) is expected to add 5-7 million in turnover sales. - European capacity catering to €50 million is about 90% utilized; plans to increase capacity by 1.5x soon to support aggressive growth in Europe. - India has current capacity of ~20,000 tons with expansions adding 9,000 tons in Q1 next year and another 15,000 tons thereafter, indicating strong growth headroom. - Strong double-digit growth is seen in Middle East, Africa, Central Asia, and Southeast Asia markets. - U.S. market initiatives are beginning to generate orders, with business expected to grow from Q4 this year and into FY '29. - Growth drivers include new CDCs, operational expansions, and leveraging innovation in emerging markets and smaller clients. - The company expects to reach double-digit return ratios (~14%) by FY '29, indicating profitable/top-line growth.

📈 Profitability & Margins

- Flavours EBIT margins expected to remain steady at 20%-22% through FY27-FY28. - Fragrances EBIT margins projected to improve from current ~8% to 13%-14% over 2-4 years, especially as outside India operations ramp up. - Blended Fragrances segment EBIT expected around 17%-18%; EBITDA margins are 14%-17%, with EBIT margins 2%-3% higher. - Overall business EBITDA expected to rise from current 13% to about 17% in next 2 years. - The company targets a 12% year-on-year revenue CAGR from FY24-25 onwards. - Return Ratios (ROE/ROCE) currently in single digits (~6%-8%), expected to improve to mid-teens (around 14%) by FY28-FY29. - New investments and capacity expansions are expected to break-even and contribute positively in 2-3 years. - Operating leverage and gross margin improvements will drive profitability gains.

🏗️ Capital Expenditure Plans

- Europe: Committed EUR 7-8 million capex, mostly done; expects another EUR 2-3 million outflow in next 6-12 months. New factory expected operational by Q4 FY26, expanding capacity 1.5x from current 90% utilization. - India: Capex of Rs. 70-80 crore over next 12-18 months focused on rebuilding facilities (Vashivali and Vanavate) post-fire and new expansions; adding 9,000 tons capacity in Q1 FY27 and further 15,000 tons later. - U.S.: Investment primarily opex for leased manufacturing and creative development centres (~$1.5-2 million invested); expecting $2-2.5 million business by end of next year. Minimal capex as manufacturing is operational lease-based. - Strategic focus on organic growth in U.S., Europe, and Southeast Asia with enhanced Creative Development Centres (CDCs) to generate new business. - Overall capex timeline: majority expected to be deployed within 12 to 18 months.

💰 Fundraising & Capital Structure

- The company anticipates a near-term increase in debt levels aligned with strategic initiatives and capacity expansion plans. - Debt is expected to remain range-bound around the current gross debt level of approximately Rs. 800 crore, with a potential variation of +/- Rs. 20-30 crore in the immediate 3 to 6 months. - No explicit mention of new equity fundraising was made during the transcript. - Focus will be on capital discipline, tighter capital allocation, and improving working capital efficiency to manage balance sheet strength. - Investments are ongoing, with committed capex in Europe (EUR 2-3 million in the next 6-12 months) and India (Rs. 70-80 crore in the next 12-18 months), partly funded through debt. - Management is working on detailed plans for cash flow and debt management, with expectations of positive cash flow from new investments starting in 2-3 years.

📋 Order Book & Pipeline

- The transcript does not provide explicit details about the current or expected order book value. - However, it mentions that the U.S. Creative Development Centre secured its first customer order, with execution expected from Q4 this year to Q1 next year. - European business showed 3% YoY growth in euro terms this quarter, indicating healthy demand. - The company is seeing green shoots and new business opportunities in the U.S., Europe, U.K., Middle East, and Southeast Asia. - There is some softness in demand in India post-GST changes, but the company expects sales momentum to recover shortly. - Customer interactions globally are encouraging, especially with smaller brands and e-commerce businesses driving growth. - Overall, the business pipeline appears promising with a phased build-up over the next 2-3 years as new facilities and markets scale.

Key Metrics

Frequently Asked Questions

What were S H Kelkar & Company Ltd Q4 FY26 results?

- The company targets a 12% year-on-year CAGR growth with FY '24-'25 as the base year. - Flavours EBIT margins expected to remain steady at 20%-22% through FY27-FY28.

What is S H Kelkar & Company Ltd share price analysis?

S H Kelkar & Company Ltd currently shows a neutral. The stock trades at a P/E of 38.1 with a market cap of ₹1,869. Investors should review the full earnings analysis for detailed insights.

Is S H Kelkar & Company Ltd planning capital expenditure?

- Europe: Committed EUR 7-8 million capex, mostly done; expects another EUR 2-3 million outflow in next 6-12 months.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.